In addition, among all predicted targets of miR-100, HOXA1 is a mammary oncogene [20] and is upregulated in human breast cancer [21]; overexpression of HOXA1 in immortalized human mammary epithelial cells was sufficient to induce aggressive tumor formation in vivo[20]. This evidence concerns the gene HOXA1 and breast carcinoma.